Shehnaaz Suliman, Director at 10x Genomics, Inc. (TXG), sold 2,207 shares at $62.73 ($140K) on 2026-08-24, disclosed to the SEC on 2026-08-26.
Scheduled sale ($140k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.73 | 561 | $35K | 25.0% |
| 2 | $63.97 | 1,646 | $105K | 75.0% |
| Total | $63.65 avg | 2,207 | $140K | 100% |
| Filing → |
| RARE | SELL | 2026-05-18 | $144K | — | Filing → |
| ALEC | SELL | 2021-12-14 | $6.5M | — | Filing → |
| ALEC | SELL | 2021-12-10 | $6.8M | — | Filing → |